MediciNova Announces Completion of Last Patient Last Visit in the MN-001-NATG-202 Clinical Trial of MN-001 (Tipelukast)

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. DFTX
6. GOOGL
7. APGE
8. HOOD
9. MU
10. IBM

Go back to MediciNova Announces Completion of Last Patient Last Visit in the MN-001-NATG-202 Clinical Trial of MN-001 (Tipelukast)
Medicinova, Inc. (NASDAQ: MNOV) Delayed: 1.30 -0.02 (1.52%)
Previous Close $1.32    52 Week High $10.16 
Open $1.31    52 Week Low $2.91 
Day High $1.32    P/E N/A 
Day Low $1.29    EPS $-0.41 
Volume 29,881